• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过放射免疫分析法测定唾液和血浆中苯妥英和苯巴比妥的浓度。

Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.

作者信息

Cook C E, Amerson E, Poole W K, Lesser P, O'Tuama L

出版信息

Clin Pharmacol Ther. 1975 Dec;18(6):742-7. doi: 10.1002/cpt1975186742.

DOI:10.1002/cpt1975186742
PMID:1204279
Abstract

Saliva and plasma levels of phenytoin (DPH) and phenobarbital (PB) in a series of epileptic patients were compared by means of a radioimmunoassat (RIA) that required only 10 mul of saliva or plasma. There was an excellent linear relation (r = 0.98) between the logarithms of the concentrations of DPH in the two fluids. The ratio saliva/plasma was remarkably constant at 0.10 and was unaffected by varying levels of PB. The ratio was close to the fraction of DPH reported unbound in plasma at 37 degrees. PB plasma and saliva levels were also closely related (r = 0.98 for logarithm of plasma and saliva levels). This relation was nonlinear [plasma ocncentration = 4.43 X (salivary concentration)0.86], but could be approximated by the ratio plasma/saliva = 3.4. The simplicity of sample collection and the sensitivity of the RIA procedure suggest that clinical monitoring of these anticonvulsant levels may be carried out by RIA on saliva samples.

摘要

通过一种仅需10微升唾液或血浆的放射免疫分析(RIA)方法,对一系列癫痫患者的唾液和血浆中苯妥英(DPH)和苯巴比妥(PB)的水平进行了比较。两种液体中DPH浓度的对数之间存在极佳的线性关系(r = 0.98)。唾液/血浆的比值非常恒定,为0.10,且不受PB不同水平的影响。该比值接近37摄氏度时血浆中未结合的DPH比例。PB的血浆和唾液水平也密切相关(血浆和唾液水平对数的r = 0.98)。这种关系是非线性的[血浆浓度 = 4.43×(唾液浓度)^0.86],但可用血浆/唾液比值 = 3.4来近似。样本采集的简便性和RIA程序的敏感性表明,这些抗惊厥药水平的临床监测可通过对唾液样本进行RIA来进行。

相似文献

1
Phenytoin and phenobarbital concentrations in saliva and plasma measured by radioimmunoassay.通过放射免疫分析法测定唾液和血浆中苯妥英和苯巴比妥的浓度。
Clin Pharmacol Ther. 1975 Dec;18(6):742-7. doi: 10.1002/cpt1975186742.
2
Evaluation of the Ames Seralyzer for the determination of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.评估Ames唾液分析仪用于测定唾液中卡马西平、苯巴比妥和苯妥英浓度的性能。
Ther Drug Monit. 1990 Sep;12(5):501-10. doi: 10.1097/00007691-199009000-00016.
3
A correlation between the levels of phenobarbital, phenytoin and valproic acid in the blood serum and in saliva from children treated due to epilepsy.
Mater Med Pol. 1989 Oct-Dec;21(4):323-6.
4
Intraindividual variability of carbamazepine, phenobarbital, and phenytoin concentrations in saliva.
Ther Drug Monit. 1991 Mar;13(2):166-71. doi: 10.1097/00007691-199103000-00013.
5
Monitoring of phenobarbitone and phenytoin therapy in small children by salivary samples.通过唾液样本监测小儿苯巴比妥和苯妥英治疗情况。
Ther Drug Monit. 1981;3(3):275-7. doi: 10.1097/00007691-198103000-00008.
6
Salivary phenytoin radioimmunoassay. A simple method of the assessment of non-protein bound drug concentrations.唾液苯妥英放射免疫测定法。一种评估非蛋白结合药物浓度的简单方法。
Eur J Clin Pharmacol. 1977;11(1):71-4. doi: 10.1007/BF00561791.
7
Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.苯妥英钠与丙戊酸盐的相互作用:癫痫患者唾液监测的重要性。
Br Med J (Clin Res Ed). 1982 Jan 2;284(6308):13-6. doi: 10.1136/bmj.284.6308.13.
8
[Monitoring therapy by analysis of the drug concentration of saliva].
Monatsschr Kinderheilkd. 1983 Jan;131(1):13-6.
9
Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients.癫痫患者大脑中苯妥英、苯巴比妥和扑米酮的浓度。
Eur J Clin Pharmacol. 1975 Oct 10;9(1):73-8. doi: 10.1007/BF00613432.
10
[Saliva phenobarbital concentration in epileptics].
Zhonghua Shen Jing Jing Shen Ke Za Zhi. 1989 Dec;22(6):369-70, 382.

引用本文的文献

1
The Analysis of Pethidine Pharmacokinetics in Newborn Saliva, Plasma, and Brain Extracellular Fluid After Prenatal Intrauterine Exposure from Pregnant Mothers Receiving Intramuscular Dose Using PBPK Modeling.使用生理药代动力学(PBPK)模型分析产前宫内暴露于接受肌肉注射剂量的母亲的新生儿唾液、血浆和脑细胞外液中的哌替啶药代动力学。
Eur J Drug Metab Pharmacokinet. 2023 May;48(3):281-300. doi: 10.1007/s13318-023-00823-x. Epub 2023 Apr 5.
2
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications.血浆蛋白结合对抗癫痫药物治疗监测的影响。
Pharmaceutics. 2021 Aug 5;13(8):1208. doi: 10.3390/pharmaceutics13081208.
3
Feasibility of Using Oral Fluid for Therapeutic Drug Monitoring of Antiepileptic Drugs.
使用唾液进行抗癫痫药物治疗药物监测的可行性
Eur J Drug Metab Pharmacokinet. 2021 Mar;46(2):205-223. doi: 10.1007/s13318-020-00661-1.
4
A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.新生儿和婴儿唾液治疗药物监测的描述性系统评价。
Br J Clin Pharmacol. 2018 Jun;84(6):1089-1108. doi: 10.1111/bcp.13553. Epub 2018 Mar 25.
5
Interpretation of oral fluid tests for drugs of abuse.滥用药物的唾液检测解读
Ann N Y Acad Sci. 2007 Mar;1098:51-103. doi: 10.1196/annals.1384.037. Epub 2007 Mar 1.
6
Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants.使用唾液样本进行治疗药物浓度监测。重点关注抗惊厥药。
Clin Pharmacokinet. 1999 Jun;36(6):453-70. doi: 10.2165/00003088-199936060-00006.
7
Drug monitoring in nonconventional biological fluids and matrices.非常规生物流体和基质中的药物监测。
Clin Pharmacokinet. 1996 Mar;30(3):211-28. doi: 10.2165/00003088-199630030-00003.
8
Effect of saliva flow rate on saliva phenytoin concentrations: implications for therapeutic monitoring.唾液流速对唾液中苯妥英浓度的影响:对治疗监测的意义。
Eur J Clin Pharmacol. 1994;46(6):565-7. doi: 10.1007/BF00196118.
9
Saliva carbamazepine and phenytoin level monitoring.唾液中卡马西平和苯妥英水平监测。
Arch Dis Child. 1981 Aug;56(8):637-40. doi: 10.1136/adc.56.8.637.
10
Serum and saliva levels of a trimethoprim-sulfamethopyrazine combination in man.人血清和唾液中甲氧苄啶-磺胺甲基吡嗪组合的水平。
Eur J Clin Pharmacol. 1981;20(2):113-8. doi: 10.1007/BF00607146.